Latest filing published 16 Oct 2026 for GRAIL, Inc., €18k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William J. Chase discloses dealings in 2 companies, chiefly GRAIL, Inc. and Intellia Therapeutics, Inc. The record holds 19 filings, for trades running from 14 April 2023 to 15 October 2026.
On the market, this insider has only ever bought: 1 purchase, €861k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 18 share grants.
The newest entry dates from 16 October 2026: a share grant of €18k, in GRAIL, Inc. The last purchase on record was published on 22 August 2025, which is 422 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations